1598. Antimicrobial Activity of the Novel β-Lactam Enhancer Combination Cefepime–Zidebactam (WCK-5222) Tested Against Gram-Negative Bacteria Isolated in United States Medical Cente...

por Castanheira, Mariana, Huband, Michael D, Flamm, Robert K, Sader, Helio S
Publicado 2019

1445. Antimicrobial Activity of Novel β-Lactamase Inhibitor Combinations Tested against Organisms Causing Complicated Urinary Tract Infections in United States Medical Centers

por Sader, Helio S, Carvalhaes, Cecilia G, Shortridge, Dee, Huband, Michael D
Publicado 2019

2217. Frequency and Antimicrobial Susceptibility of Bacteria Isolated from Patients Hospitalized with Pneumonia in US Medical Centers During 2018

por Sader, Helio S, Huband, Michael D, Carvalhaes, Cecilia G, Castanheira, Mariana
Publicado 2019

2176. In Vitro Evaluation of Delafloxacin Activity Against Contemporary US Isolates from Cystic Fibrosis Patients Hospitalized with Pneumonia: Results from the SENTRY Antimicrobial...

por Shortridge, Dee, Streit, Jennifer M, Huband, Michael D, Castanheira, Mariana
Publicado 2022

In Vitro Activity of Omadacycline and Comparator Compounds Against Gram-positive Isolates Collected in the USA During 2016 as Part of a Global Surveillance Program

por Huband, Michael D, Pfaller, Michael a, Sader, Helio S, Flamm, Robert K
Publicado 2017

Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program

por Pfaller, Michael A., Huband, Michael D., Shortridge, Dee, Flamm, Robert K.
Publicado 2018

1582. Delafloxacin Activity Against Drug-Resistant Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, and Moraxella catarrhalis from US Medical Centers (...

por Shortridge, Dee, Streit, Jennifer M, Huband, Michael D, Flamm, Robert K
Publicado 2019

1463. Activity of Delafloxacin against Multi-Drug-Resistant Fastidious Respiratory Pathogens from European Medical Centers (2014-2019)

por Shorttidge, Dee, Streit, Jennifer M, Huband, Michael D, Flamm, Robert K
Publicado 2020

1292. Activity of Omadacycline and Comparators Against 876 Bacterial Clinical Isolates from Patients with Bone and Joint Infections in the United States and Europe (2015–2022)

por Huband, Michael D, Pfaller, Michael A, Fedler, Kelley, Sader, Helio S, Castanheira, Mariana
Publicado 2023

1948. Rise of Candida auris Infections Worldwide and Trends on the Activity of Fosmanogepix and Comparator Agents against C. auris Causing Invasive Infections

por Carvalhaes, Cecilia G, Huband, Michael D, Rhomberg, Paul, Hatch, Beth, Castanheira, Mariana
Publicado 2023

155. In Vitro Evaluation of Delafloxacin Activity Against Contemporary US Isolates from Community-Acquired Pneumonia and Community-Acquired Lower Respiratory Tract Infections: Resu...

por Shortridge, Dee, Streit, Jennifer M, Huband, Michael D, Castanheira, Mariana, Castanheira, Mariana
Publicado 2021

2043. In Vitro Activity of Manogepix Against 2,810 Fungal Isolates from the SENTRY Surveillance Program (2020-2021) Stratified by Infection Type

por Huband, Michael D, Pfaller, Michael, Carvalhaes, Cecilia G, Bien, Paul, Castanheira, Mariana
Publicado 2022

Determination of MIC Quality Control Ranges for Ceftibuten-Avibactam (Fixed 4 μg/mL), a Novel β-Lactam/β-Lactamase Inhibitor Combination

por Huband, Michael D., Fedler, Kelley A., Sader, Helio S., Stone, Gregory G., Castanheira, Mariana
Publicado 2023

2139. High Rates of Non-Susceptibility to Common Oral Antibiotics Among Streptococcus pneumoniae Clinical Isolates from the United States (2019-2021)

por Deshpande, Lalitagauri M, Huband, Michael D, Charbon, Sarah, Castanheira, Mariana, Mendes, Rodrigo E
Publicado 2023

2517. Activity of Sulbactam-durlobactam, Antibacterial Combinations, and Comparators Against a Challenge Set of 66 Acinetobacter baumannii-calcoaceticus Species Complex Isolates

por Huband, Michael D, Mendes, Rodrigo E, Morgan, Gina M, Huynh, Holly, Castanheira, Mariana
Publicado 2023

1253. In Vitro Activity of Omadacycline against 7000 Bacterial Pathogens from the United States Stratified by Infection Type (2019)

por Huband, Michael D, Pfaller, Michael A, Streit, Jennifer M, Sader, Helio S, Castanheira, Mariana
Publicado 2020

1687. Antimicrobial Activity of Ceftibuten-Avibactam against a Global Collection of Enterobacterales from Patients with Complicated Urinary Tract Infections (2021)

por Sader, Helio S, Carvalhaes, Cecilia G, Huband, Michael D, Mendes, Rodrigo E, Castanheira, Mariana
Publicado 2022

Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021)

por Sader, Helio S., Carvalhaes, Cecilia G., Huband, Michael D., Mendes, Rodrigo E., Castanheira, Mariana
Publicado 2023

Activity of Delafloxacin When Tested Against Bacterial Surveillance Isolates Collected in the US and Europe During 2014–2016 as Part of a Global Surveillance Program

por Flamm, Robert K, Shortridge, Dee, Huband, Michael D, McCurdy, Sandra, Pfaller, Michael A
Publicado 2017

In Vitro Evaluation of Delafloxacin Activity when Tested Against Contemporary community-Acquired Bacterial Respiratory Tract Infection Isolates (2014–2016): Results from the Sentry...

por Shortridge, Dee, Streit, Jennifer M, Huband, Michael D, Rhomberg, Paul R, Flamm, Robert K
Publicado 2017